AngioDynamics Doubles Vascular Access Biz With Navilyst Acquisition

By Zach Miners / Email the Author / “The Gray Sheet” Feb. 6, 2012, Vol. 38, No. 06
Mergers & Acquisitions / Word Count: 921 / Article # 01120206008

Executive Summary

Deal worth $372 million makes AngioDynamics the clear number-two competitor in the global vascular access market, second only to Bard.

Purchase this Article

$50.00 Buy Now

For $50.00, purchase this 921-word article and receive immediate online access. 100% Satisfaction Guarantee.

View a complete sample article »

Already a Subscriber?

Log in for complete access.

Questions?

Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.

+ Show All | – Hide All

Offers & Events

Topics Covered in this Article

Click a keyword for related articles.
Subjects
Deals & Dealmaking Strategies
Industries
Medical Devices
Implantable Devices
Diagnostic Imaging
Therapeutic Area(s) of Focus
Cardiovascular
Peripheral Vascular Disease
Companies
AngioDynamics Inc.
Navilyst Medical Inc.

Log In

Email Address

Password

Remember Me

Forgot your password?

Don’t Have an Account?

If your employer has a site license, create your account to begin using it. Simply click ‘Create An Account’ button below to register now.

Otherwise, please explore our free content subscriptions.

Create an account

Enter the email address associated with your account and a temporary password will be sent to you.

Email Address

Need help? Contact us at (800) 332-2181, +1 (908) 547-2159, or custcare@elsevier.com

Email Article

* Required field

* To:

For multiple recipients, separate email addresses with a semi-colon.

* Your Name:

* Your Email:

Subject: AngioDynamics Doubles Vascular Access Biz With Navilyst Acquisition

* Add a personalized message to your email:

Please Note: Only individuals with subscriptions to “The Gray Sheet” will be able to access the full article. All other readers will be directed to the abstract and may purchase the article.

or Cancel